Abstract:
Objective To explore the expression of long non-coding RNA (lncRNA) urothelial carcinoembryonic antigen 1 (UCA1) in lung adenocarcinoma A549 cells and its influence on key enzymes involved in sugar metabolism, cell invasion, and metastasis.
Methods The lncRNA UCA1 silencing and its control stable transfected lung adenocarcinoma A549 cells were constructed, the small interfering RNA (siRNA) transfected cells were divided into NC group (negative control group, transfected with siRNA-UCA1 sequence) and siRNA-UCA1 group (transfected with siRNA-UCA1 knockdown sequence). Quantitative real-time PCR and Western blot analyses were used to detect changes in the levels of glucose transporter protein (GLUT)1, hexokinase (HK)2 and pyruvate kinase isozymes M (PKM)2 related to glucose metabolism. Transwell and scratch tests were conducted to detect the invasion and migration ability of siRNA-UCA1. 18F-Fluorodeoxyglucose (FDG) uptake experiment was used to detect the uptake rate of siRNA-UCA1. T test was used to compare the measurement data.
Results UCA1 was highly expressed in lung adenocarcinoma A549 cell line. Compared with the NC group, the siRNA-UCA1 group can inhibit the expression of GLUT1, HK2, and PKM2 in lung adenocarcinoma A549 cells (t=19.66, 5.81, 11.98; all P<0.001), and the protein expression levels of the three significantly decreased (t=61.35, 145.90, 88.19; all P<0.001). Compared with the NC group, the siRNA-UCA1 group's migration ability and 18F-FDG uptake rate of A549 cells were significantly reduced (t=19.43, 7.71, 5.79; all P<0.05).
Conclusions LncRNA UCA1 can affected the key enzymes of glucose metabolism and promoted the metastasis ability of lung adenocarcinoma. Thus, lncRNA UCA1 may be a new diagnostic index and therapeutic target for lung cancer.